Content deleted Content added
m Open access bot: doi updated in citation with #oabot. |
m Open access bot: doi updated in citation with #oabot. |
||
(5 intermediate revisions by 5 users not shown) | |||
Line 1:
{{Short description|Mammalian protein found in Homo sapiens}}
{{cs1 config|name-list-style=vanc|display-authors=6}}
{{Infobox_gene}}
The '''glycogen debranching enzyme''', in humans, is the protein encoded by the [[gene]] ''AGL''.<ref name=Gene/> This enzyme is essential for the [[Glycogenolysis|breakdown]] of [[glycogen]], which serves as a store of glucose in the body. It has separate glucosyltransferase and glucosidase activities.<ref name="Song"/><ref name="Bao"/>
Line 35 ⟶ 36:
}}
|}
== Structure and activity ==
Line 52 ⟶ 54:
[[File:Hypothesized substraight binding ___location.png|thumb|center|Hypothesized sidechain binding sites|600px]]
The structure of the ''Candida glabrata'' GDE has been reported.<ref>{{
== Genetic ___location ==
The official name for the gene is "amylo-α-1,6-glucosidase, 4-α-glucanotransferase", with the official symbol AGL. AGL is an autosomal gene found on chromosome 1p21.<ref name=Hondoh/> The AGL gene provides instructions for making several different versions, known as isoforms, of the glycogen debranching enzyme. These isoforms vary by size and are expressed in different tissues, such as liver and muscle. This gene has been studied in great detail, because mutation at this gene is the cause of Glycogen Storage Disease Type III.<ref name=Gene/>
The gene is 85 kb long, has 35 [[exon]]s and encodes for a 7.0 kb mRNA. Translation of the gene begins at exon 3, which encodes for the first 27 amino acids of the AGL gene, because the first two exons (68kb) contain the 5' untranslated region. Exons 4-35 encode the remaining 1505 amino acids of the AGL gene.<ref name= Bao/>
Studies produced by the department of pediatrics at Duke University suggest that the human AGL gene contains at minimum 2 promotor regions, sites where the transcription of the gene begins, that result in differential expression of isoform, different forms of the same protein, mRNAs in a manner that is specific for different tissues.<ref name = Gillard /><ref name=Ding />
Line 71 ⟶ 73:
{{Reflist | colwidth = 35em | refs =
<ref name="Song">{{cite journal | vauthors = Song HN, Jung TY, Park JT, Park BC, Myung PK, Boos W, Woo EJ, Park KH | title = Structural rationale for the short branched substrate specificity of the glycogen debranching enzyme GlgX | journal = Proteins | volume = 78 | issue = 8 | pages =
<ref name="Bao">{{cite journal | vauthors = Bao Y, Dawson TL, Chen YT | title = Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5' flanking region | journal = Genomics | volume = 38 | issue = 2 | pages =
<ref name="Berg">{{cite book |
<ref name="Dauvillée">{{cite journal | vauthors = Dauvillée D, Kinderf IS, Li Z, Kosar-Hashemi B, Samuel MS, Rampling L, Ball S, Morell MK | title = Role of the Escherichia coli glgX gene in glycogen metabolism | journal =
<ref name="Nakayama">{{cite journal | vauthors = Nakayama A, Yamamoto K, Tabata S | title = Identification of the catalytic residues of bifunctional glycogen debranching enzyme | journal =
<ref name="Chen">{{cite journal | vauthors = Chen YT, He JK, Ding JH, Brown BI | title = Glycogen debranching enzyme: purification, antibody characterization, and immunoblot analyses of type III glycogen storage disease | journal =
<ref name="UniProt P35573">{{cite web | url = https://www.uniprot.org/uniprot/P35573 | title = Glycogen debranching enzyme - Homo sapiens (Human) | publisher = UniProt }}</ref>
<ref name="Gillard_80">{{cite journal | vauthors = Gillard BK, White RC, Zingaro RA, Nelson TE | title = Amylo-1,6-glucosidase/4-alpha-glucanotransferase. Reaction of rabbit muscle debranching enzyme with an active site-directed irreversible inhibitor, 1-S-dimethylarsino-1-thio-beta-D-glucopyranoside | journal =
<ref name="Gillard">{{cite journal | vauthors = Gillard BK, Nelson TE | title = Amylo-1,6-glucosidase/4-alpha-glucanotransferase: use of reversible substrate model inhibitors to study the binding and active sites of rabbit muscle debranching enzyme | journal = Biochemistry | volume = 16 | issue = 18 | pages =
<ref name="Woo">{{cite journal | vauthors = Woo EJ, Lee S, Cha H, Park JT, Yoon SM, Song HN, Park KH | title = Structural insight into the bifunctional mechanism of the glycogen-debranching enzyme TreX from the archaeon Sulfolobus solfataricus | journal =
<ref name="UniProt A8QX06">{{cite web | url = https://www.uniprot.org/uniprot/A8QX06 | title = TreX - Actinoplanes sp. SN223/29 | publisher = UniProt }}</ref>
Line 99 ⟶ 101:
<ref name="Park">{{cite journal |vauthors=Park JT, Park HS, Kang HK, Hong JS, Cha H, Woo EJ, Kim JW, Kim MJ, Boos W, Lee S, Park KH | title = Oligomeric and functional properties of a debranching enzyme (TreX) from the archaeon Sulfobus solfataricus P2. | journal = Biocatalysis and Biotransformation | year = 2008 | volume = 26 | issue = 1–2 | pages = 76–85 | doi = 10.1080/10242420701806652 | s2cid = 83831481 }}</ref>
<ref name="Talente">{{cite journal | vauthors = Talente GM, Coleman RA, Alter C, Baker L, Brown BI, Cannon RA, Chen YT, Crigler JF, Ferreira P, Haworth JC, Herman GE, Issenman RM, Keating JP, Linde R, Roe TF, Senior B, Wolfsdorf JI
<ref name="Monga">{{cite book |
<ref name="Hondoh">{{cite journal
<ref name="MCCarter">{{cite journal | vauthors = McCarter JD, Withers SG | title = Mechanisms of enzymatic glycoside hydrolysis | journal =
<ref name="Yamamoto">{{cite journal | vauthors = Yamamoto E, Makino Y, Omichi K | title = Active site mapping of amylo-alpha-1,6-glucosidase in porcine liver glycogen debranching enzyme using fluorogenic 6-O-alpha-glucosyl-maltooligosaccharides | journal =
<ref name="Hers">{{cite journal | vauthors = Hers HG, Verhue W, Van hoof F | title = The determination of amylo-1,6-glucosidase | journal =
<ref name="Ding">{{cite journal | vauthors = Ding JH, de Barsy T, Brown BI, Coleman RA, Chen YT | title = Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III | journal =
<ref name="Molecule">{{cite journal |
<ref name="Gene">{{cite web | url =
<ref name="Shen">{{cite journal | vauthors = Shen J, Bao Y, Liu HM, Lee P, Leonard JV, Chen YT | title = Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle | journal =
<ref name="Kishnan">{{cite journal | vauthors = Kishnani PS, Austin SL, Arn P, Bali DS, Boney A, Case LE, Chung WK, Desai DM, El-Gharbawy A, Haller R, Smit GP, Smith AD, Hobson-Webb LD, Wechsler SB, Weinstein DA, Watson MS
}}
== External links ==
{{Commons category}}
* [https://www.ncbi.nlm.nih.gov/
* [https://
* {{MeSH name|Glycogen+debranching+enzyme}}
Line 136 ⟶ 138:
{{DEFAULTSORT:Glycogen Debranching Enzyme}}
[[Category:Carbohydrate metabolism]]
[[Category:EC 2.4.1]]
[[Category:EC 3.2.1]]
|